Search - tctmd.com

Displaying 441 - 460 of 724

Sort: Relevancy | Date

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

News Daily News

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

Michael O'Riordan

February 01, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

New Advanced Training Outlined for Future Vascular Medicine Specialists

Michael O'Riordan

January 21, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Daily News

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Michael O'Riordan

January 12, 2021

News Daily News

Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan

Shelley Wood

January 07, 2021

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Review Spotlights SCAD Diagnosis and Treatment

L.A. McKeown

December 15, 2020

News Daily News

Knowing Comorbidities, Medication Use May Save Lives in COVID-19

Michael O'Riordan

December 15, 2020

News Features

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

Todd Neale

December 14, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

News Features

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Michael O'Riordan

December 02, 2020

Advertisement

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

New Advanced Training Outlined for Future Vascular Medicine Specialists

FDA Approves Vericiguat for High-risk Patients With HF

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Funding the Future: How Industry Support for CV Trials Could Evolve

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Review Spotlights SCAD Diagnosis and Treatment

Knowing Comorbidities, Medication Use May Save Lives in COVID-19

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Even Low-Dose Steroids Increase the Risk of CVD

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content